Corona viruses are a wide group of pathogens that affect both humans and animals. It spreads in humans by human-to-human interaction, as seen with MERS and SARS. Close contact allows the virus to spread by droplets from coughs, sneezes, and conversations. The incubation period varies from 2 to 14 days, and it is still unknown in many cases. Mild symptoms such as sore throat, headache, cough, and malaise are treated with antipyretics and antitussives, as well as nutritive treatment, depending on the symptoms.Oxygen therapy, anticoagulation, and corticosteroids are given with antiviral drugs for mild symptoms. The demand for supply must be maintained. In extreme cases, drug treatment should be continued and oxygenation maintained early in the disease; but, as the disease progresses to ARDS, a non-invasive technique providing oxygen via a mask or nasal cannula and preserving SpO2 and FiO2 is used first. If the condition worsens to the point that the Lung no longer functions, a compliant endotracheal intubation is performed in order to administer artificial ventilation in an environment where expertise is available. Patients with septic shock are started on antimicrobial treatment, fluid loadings are maintained, and vasopressors are administered. Glucocorticoids can be used for a limited time to treat a patient’s deteriorating condition. Airway Management of COVID19 and LowCost Ventilators-aboonor bane? As a result, disease prevention at the earliest stage is considered a condemnatory measure. However, one must be prepared for any mishaps in the manifestation of disease as it progresses to complication. Invasive procedures such as mechanical ventilation and non-invasive procedures such as nasal cannula oxygenation must be used successfully, depending on the patient’s capacity for reaction to the care offered. Given the unpredictability of the future in relation to the disease, it would be advantageous if the country were to be equipped in advance with manufactured low-cost ventilators.